Literature DB >> 29744756

Regression of fibrosis in pediatric liver diseases.

Vikrant Sood1, Bikrant Bihari Lal2, Archana Rastogi3, Rajeev Khanna2, Dinesh Rawat2, Seema Alam2.   

Abstract

The concept of irreversibility of cirrhosis has been challenged in the recent past with literature in this regard, albeit still scarce, now being accumulated across all age groups, etiologies, and geographical regions. This small series of nine pediatric cases elegantly recapitulates the concept of regression of hepatic fibrosis/cirrhosis and paves way for further detailed studies to enable development of therapeutic anti-fibrotic modalities in future.

Entities:  

Keywords:  Hepatic fibrosis; Pediatric liver diseases; Regression

Mesh:

Year:  2018        PMID: 29744756     DOI: 10.1007/s12664-018-0847-8

Source DB:  PubMed          Journal:  Indian J Gastroenterol        ISSN: 0254-8860


  14 in total

1.  Complete regression of cirrhosis after immunosuppressive treatment in autoimmune hepatitis.

Authors:  Gonca Ustundag; Zarife Kuloglu; Ceyda Tuna Kirsaçlioğlu; Aydan Kansu; Esra Erden; Nurten Girgin
Journal:  Pediatr Int       Date:  2008-10       Impact factor: 1.524

Review 2.  Hepatic fibrosis. Correlation of biochemical and morphologic investigations.

Authors:  H Popper; S Uenfriend
Journal:  Am J Med       Date:  1970-11       Impact factor: 4.965

Review 3.  Cirrhosis of the liver: a reversible disease?

Authors:  R Pérez-Tamayo
Journal:  Pathol Annu       Date:  1979

4.  Regression of human cirrhosis. Morphologic features and the genesis of incomplete septal cirrhosis.

Authors:  I R Wanless; E Nakashima; M Sherman
Journal:  Arch Pathol Lab Med       Date:  2000-11       Impact factor: 5.534

5.  Biliary diversion for progressive familial intrahepatic cholestasis: improved liver morphology and bile acid profile.

Authors:  Amethyst C Kurbegov; Kenneth D R Setchell; Joel E Haas; Gary W Mierau; Michael Narkewicz; John D Bancroft; Frederick Karrer; Ronald J Sokol
Journal:  Gastroenterology       Date:  2003-10       Impact factor: 22.682

6.  Reversal of liver fibrosis.

Authors:  Mona H Ismail; Massimo Pinzani
Journal:  Saudi J Gastroenterol       Date:  2009-01       Impact factor: 2.485

7.  Chronic hepatitis B in children after e antigen seroclearance: final report of a 29-year longitudinal study.

Authors:  Flavia Bortolotti; Maria Guido; Samuela Bartolacci; Paolo Cadrobbi; Carlo Crivellaro; Franco Noventa; Giulia Morsica; Maria Moriondo; Angelo Gatta
Journal:  Hepatology       Date:  2006-03       Impact factor: 17.425

Review 8.  Grading and staging systems for inflammation and fibrosis in chronic liver diseases.

Authors:  Zachary D Goodman
Journal:  J Hepatol       Date:  2007-07-30       Impact factor: 25.083

Review 9.  Reversal of liver cirrhosis: a desirable clinical outcome and its pathogenic background.

Authors:  Flavia Bortolotti; Maria Guido
Journal:  J Pediatr Gastroenterol Nutr       Date:  2007-04       Impact factor: 2.839

10.  Histological improvement of liver fibrosis in well-treated patients with autoimmune hepatitis: A cohort study.

Authors:  Åsa D Borssén; Richard Palmqvist; Stergios Kechagias; Hanns-Ulrich Marschall; Annika Bergquist; Fredrik Rorsman; Ola Weiland; Hans Verbaan; Nils Nyhlin; Emma Nilsson; Mårten Werner
Journal:  Medicine (Baltimore)       Date:  2017-08       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.